BPC-157 Cycle: Schedules, and the Maths Beneath
A bpc 157 cycle is described in weeks, but the vial answers in draws. The arithmetic linking mg per mL, syringe units and how long one vial actually lasts.
MEDICAL DISCLAIMER: Educational research guidelines only. Lyophilized peptides are investigational chemical compounds and are NOT approved for human consumption, diagnosis, or therapy. Consult a licensed physician before any research application.
The question underneath most searches for a bpc 157 cycle is more concrete than the word suggests: how many draws does one vial give, how long does that take to work through, and does the reconstitution volume change the answer.
Two of those have exact arithmetic answers. The third has an answer that surprises most people asking about a bpc 157 cycle, and it is worth stating up front: the volume of water added does not change how long a vial lasts. It changes what a syringe graduation means, which is a different question.
Lowest cost per milligram we track
BPC-157 — Ascension Peptides
Research material with no published assay for this product. Both drop by half with the code below.
The Wolverine Stack is BPC-157 10 mg combined with TB-500 10 mg in one vial, so its per-mg figure spans both compounds. Quantity tiers take 3%, 5% or 10% off the list price; free shipping starts at $250.
- No third-party assay published for this product
- Free carriage over $250
- Same-day dispatch before 2pm CST
Laboratory research material only, not for human consumption. Affiliate links: we may earn a commission at no additional cost to you. Figures checked August 19, 2026.
What a bpc 157 cycle borrows the word from
Cycle is imported vocabulary. In a research setting the equivalent idea is an exposure window, and an exposure window is defined by the experiment rather than by convention. A rat tendon healing study defines a window because the model has a healing timeline and the tissue is examined at a chosen point. A cell culture experiment defines an exposure duration because the assay is read at a fixed time. Neither window is a template. Both are properties of the study design.
Outside research the word carries an implication it has not earned here, which is that a schedule of a certain length has been shown to be the right length. For BPC-157 that showing does not exist. The efficacy literature is overwhelmingly rat work and cell culture work, much of it from a small number of research groups, covering tendon, ligament, muscle and gut outcomes, and its exposure windows describe those experiments in those species.
Human trials are registered. [NCT07803250](https://clinicaltrials.gov/study/NCT07803250) covers recovery after rotator cuff repair and is listed as not yet recruiting. [NCT02637284](https://clinicaltrials.gov/study/NCT02637284) is a Phase 1 safety and pharmacokinetics study with status listed as unknown. None has published efficacy results. So it is wrong to say no human trials exist, and equally wrong to present any circulating schedule as validated by them. Nothing on this page is a schedule for a person; the calculations that follow are laboratory inventory arithmetic.
The arithmetic that actually governs a vial
Three quantities do all the work.
The labelled mass is what the vial claims to contain, commonly 5 mg or 10 mg. The added volume is the liquid put in, chosen by whoever prepares it. Concentration is the first divided by the second, and a U-100 syringe puts 100 units in 1 mL, making one unit 0.01 mL.
From those, two separate calculations follow, and confusing them is the source of most of the confusion around cycle length.
The first calculation is resolution. Mass per unit equals concentration multiplied by 0.01 mL. A 10 mg vial in 1 mL gives 10 mg per mL, so a unit holds 100 mcg. The same vial in 5 mL gives 2 mg per mL, so a unit holds 20 mcg. That is a fivefold difference in what a single graduation means.
The second calculation is inventory. Number of draws equals labelled mass divided by the mass per draw. A 10 mg vial divided into 250 mcg portions gives 10000 / 250 = 40 draws. Water does not appear anywhere in that expression. Add 1 mL or add 5 mL, the vial still holds 10 mg and still yields 40 draws of 250 mcg. Only the number of units you pull each time changes.
The stability window is the constraint people forget
Inventory arithmetic assumes the whole vial gets used. Reconstituted peptide in solution does not keep indefinitely, so the practical limit on a vial is often the shorter of two numbers: how many draws it contains, and how many draws fit inside whatever storage window is being applied.
Work an example with an assumed policy, since the assumption is the point and no stability figure for this compound is asserted here. Suppose a laboratory applies a 28 day limit to any reconstituted vial held refrigerated. A 10 mg vial yielding 40 draws, worked through at one draw per working session with one session a day, needs 40 days. It runs 12 days past the policy. Twelve draws' worth of labelled material, 3 mg of it, would be discarded rather than used.
That changes the sensible purchase. Under the same assumed policy, a 5 mg vial yields 20 draws of 250 mcg, finishes inside the window, and wastes nothing, even though its cost per mg is higher. The cheaper vial per mg bought is not the cheaper vial per mg used, and the crossover point is set by the storage window rather than by the price list.
Vial longevity, worked out
The divisors below are round numbers chosen to make the arithmetic legible. They are not recommended amounts, and no amount is recommended anywhere on this page.
| Vial label | Water added | Concentration | Units holding 250 mcg | Draws of 250 mcg in the vial |
|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg per mL | 5 | 20 |
| 5 mg | 2.5 mL | 2 mg per mL | 12.5 | 20 |
| 10 mg | 1 mL | 10 mg per mL | 2.5 | 40 |
| 10 mg | 2 mL | 5 mg per mL | 5 | 40 |
| 10 mg | 5 mL | 2 mg per mL | 12.5 | 40 |
Read down the last column and it does not move within a vial size. Read down the fourth column and it moves by a factor of five. That contrast is the whole lesson: reconstitution volume is a measurement decision, not a supply decision.
The fourth column also shows which volumes are workable. A draw of 2.5 units is a poor target on a barrel graduated in whole units, and 12.5 units is no better. The 10 mg vial in 2 mL, landing on a clean 5 units, is the row a person doing this arithmetic would pick, and they would pick it for readability rather than for any biological reason.
What none of this establishes
The calculations above are exact and they are narrow. They take the printed label as true, which independent assay is the only way to confirm, and a compound sold as a research chemical carries no requirement that the label match the contents. BPC-157 holds no marketing authorisation from the FDA, the EMA or the MHRA.
More to the point for anyone searching for a bpc 157 cycle length: no arithmetic here says anything about how long an exposure should last, because that question has no answer in the current literature. The rat work defines windows for rat experiments. The registered human trials will define windows for their protocols and have not reported. Everything in between is convention.
Related reading on this compound: [what the published protocols ran](/guides/bpc-157-protocol), [what BPC-157 actually is](/guides/what-is-bpc-157), [what is known about side effects](/guides/bpc-157-side-effects).
Frequently Asked Questions
Does adding more water make a vial last longer?expand_more
No. The vial holds the labelled mass regardless of the volume added, so the number of draws of a given mass is fixed by the label and the divisor. More water lowers the concentration and raises the number of units per draw, which changes the reading on the barrel and nothing about the supply.
Which reconstitution volume is correct?expand_more
None is correct in a chemical sense. The useful criterion is whether the masses being measured land on whole graduations. Working backwards from the target to the volume is the practical move: pick the concentration that puts your figure on a readable line, then check the vial can be used inside your storage window at that concentration.
Why do published schedules vary so much?expand_more
Because a published bpc 157 cycle is a convention passed between sources rather than a result carried out of a study, and because many of them quote units without a concentration, which makes two schedules that look different identical, or two that look identical several times apart. Converting everything to mass per draw before comparing removes most of the apparent variation.
Is a 10 mg vial always the better buy?expand_more
Per mg bought, usually. Per mg used, only if the whole vial can be worked through inside the storage window being applied. The worked example above shows a case where the larger vial loses on that second measure despite winning on the first, and which one applies depends on the window, not the price.
Do the rat exposure windows suggest a length?expand_more
They describe rat experiments. A window in a rat tendon model is chosen to match that model's healing timeline and the point at which tissue is examined, and it carries no information about a person. Converting one into a human schedule requires assumptions about clearance and route that the species difference does not support, and there is no completed human efficacy trial to check the result against.